Life Molecular Imaging
Caroline Papin has a diverse background in the pharmaceutical and biotechnology industries. Caroline currently holds the position of Head of Analytical Development at Life Molecular Imaging, where they have been since 2018. Prior to this, they worked at Molecular NeuroImaging for a number of years, progressing from Senior Chemist to Director of QC Chemistry. Between 2006 and 2009, they pursued a Ph.D. in organic chemistry at Paris-Sud University (Paris XI). Caroline also gained experience through internships at Sanofi-Aventis and Novartis during the early stages of their career.
Caroline Papin holds a Ph.D. in Chemistry from Paris-Sud University (Paris XI), which they obtained from 2006 to 2009. Prior to that, they pursued a Master 2 degree in Chemical and Biomolecular Engineering from Ecole Nationale Supérieure de Chimie de Montpellier from 2005 to 2006. Caroline also completed their undergraduate studies at Ecole Nationale Supérieure de Chimie de Mulhouse, where they earned a degree in Chemistry as an Ingénieur chimiste from 2002 to 2006. Finally, they began their education at Ecole Nationale Supérieure de Chimie de Rennes in 2000, but no specific degree information is provided for this time frame.
This person is not in any offices
Life Molecular Imaging
Life Molecular Imaging (formerly Piramal Imaging) is now part of the Alliance Medical Group, an integrated business including research and development laboratories, a network of cyclotrons, radiopharmacies and imaging facilities. These combined services allow physicians, pharma industry and academia greater access to established and innovative imaging agents for clinical trials and clinical routine. With an ever increasing demand of effective care as well as a growing global awareness of healthcare efficiency and costs, improved diagnostic tools offer a unique opportunity for: - Earlier detection and better characterization of diseases - Determining the right therapy at the right dose for a patient (precision medicine) - Monitoring therapy response As a global leader in the field of radiopharmaceuticals, Life Molecular Imaging is developing a product portfolio of innovative molecular imaging probes that address major clinical needs in neurology, oncology, and cardiology. Life Molecular Imaging is supporting use of imaging biomarkers in several major therapeutic trials in Alzheimer’s disease. Imprint: Life Molecular Imaging GmbH Tegeler Strasse 6-7 13353 Berlin Germany Telefon: +49 30 461 124603 Fax: +49 30 461 124 629 Email: info@life-mi.com Internet: http://www.life-mi.com Managing Directors: Dr. Ludger Dinkelborg Michel Jongens Chamber of Commerce: Amtsgericht Charlottenburg HRB 136823 B Sales tax identification number: DE 283685037 Data Protection Policy: https://life-mi.com/data-protection/